The GCC healthcare market is projected to grow from 121.9 billion dollars in 2025 to 170.5 billion dollars by 2030. Saudi Arabia and the UAE accounted for nearly 92 percent of approximately 400 GCC healthcare transactions between 2021 and 2025. For a global consulting firm advising a private healthcare operator on market entry strategy across the GCC, the stakes were significant.
The consulting firm had used their existing expert network for the initial rounds of research. The conversations were professional and informative at a general level. What they had not produced was emirate-specific intelligence. The experts who had been sourced had experience across the GCC but had not operated within the specific regulatory frameworks the project required. They could describe the market. They could not describe the specific policy environment governing private operator entry in Abu Dhabi versus Dubai.
The consulting team brought the project to Nextyn.
Within 48 hours Nextyn delivered profiles including a former Abu Dhabi Ministry of Health official who had been directly involved in shaping the private operator regulatory framework that would govern the client's market entry, a healthcare investor who had backed three businesses in the same segment across Abu Dhabi and Dubai, and a former senior executive from a regional private hospital chain who had managed the DOH and DHA licensing process simultaneously.
The former Ministry of Health official described a specific element of the Abu Dhabi private operator licensing framework that had been updated six months earlier, affecting the minimum capital requirements and staffing ratios for new entrants in the target speciality category. The update had not appeared in any published regulatory guidance the consulting team had reviewed. It had been communicated through a circular to existing licenced operators.
The healthcare investor provided context on how the Abu Dhabi and Dubai markets had diverged in their treatment of international private operators over the preceding two years. Abu Dhabi had become more receptive to international brand partnerships in premium segments. Dubai had moved toward favouring local operator partnerships in mainstream healthcare categories.
The consulting firm's original recommendation had treated the UAE as a single market entry point. The intelligence changed both the market sequence and the operator model. The recommendation was revised to enter Abu Dhabi first with an international brand partnership structure. The Dubai market entry was deferred to a second phase with a revised model reflecting the DHA's current preference for local operator partnerships.
The consulting firm submitted the revised strategy to their client. The market entry timeline was extended by eight months relative to the original plan. The revised plan was more defensible, more specific, and built on operational intelligence rather than market analysis alone.
A consulting firm entering the GCC healthcare market with globally-sourced experts will produce a credible market overview. A consulting firm with locally-sourced practitioners will produce an operationally accurate market entry strategy. The difference is the difference between a strategy that survives the implementation phase and one that does not. The GCC healthcare market is not adequately covered by global expert databases. The practitioners who understand the emirate-specific regulatory environment are found through networks built in market, not databases built remotely.